[PDF][PDF] Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis

P Xu, C Chen, Y Zhang, M Dzieciatkowska, BC Brown… - Cell metabolism, 2022 - cell.com
Due to lack of nuclei and de novo protein synthesis, post-translational modification (PTM) is
imperative for erythrocytes to regulate oxygen (O 2) delivery and combat tissue hypoxia …

[HTML][HTML] Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis

P Xu, C Chen, Y Zhang, M Dzieciatkowska, BC Brown… - Cell Metabolism, 2022 - Elsevier
Due to lack of nuclei and de novo protein synthesis, post-translational modification (PTM) is
imperative for erythrocytes to regulate oxygen (O 2) delivery and combat tissue hypoxia …

Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis.

P Xu, C Chen, Y Zhang, M Dzieciatkowska… - Cell …, 2022 - europepmc.org
Due to lack of nuclei and de novo protein synthesis, post-translational modification (PTM) is
imperative for erythrocytes to regulate oxygen (O 2) delivery and combat tissue hypoxia …

[HTML][HTML] Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis

P Xu, C Chen, Y Zhang, M Dzieciatkowska… - Cell …, 2022 - ncbi.nlm.nih.gov
Due to lack of nuclei and de novo protein synthesis, post-translational modification (PTM) is
imperative for erythrocytes to regulate oxygen (O 2) delivery and combat tissue hypoxia …

Erythrocyte transglutaminase-2 combats hypoxia and chronic kidney disease by promoting oxygen delivery and carnitine homeostasis

P Xu, C Chen, Y Zhang, M Dzieciatkowska… - Cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Due to lack of nuclei and de novo protein synthesis, post-translational modification (PTM) is
imperative for erythrocytes to regulate oxygen (O 2) delivery and combat tissue hypoxia …